It’s been a crucial week for The Chemours Company (NYSE:CC); here’s what analysts have to say.

The Chemours Company (NYSE:CC) Logo
Investors sentiment increased to Infinity in Q3 2018. Its up Infinity, from 0 in 2018Q2. It is positive, as 0 investors sold The Chemours Company shares while 1 reduced holdings. 0 funds opened positions while 1 raised stakes. 7,525 shares or 0.07% less from 7,530 shares in 2018Q2 were reported.
Gemmer Asset Ltd, a California-based fund reported 746 shares. Balasa Dinverno And Foltz Ltd Limited Liability Company invested 0.03% in The Chemours Company (NYSE:CC).

The Chemours Company (NYSE:CC) Ratings Coverage

Among 5 analysts covering Chemours (NYSE:CC), 2 have Buy rating, 0 Sell and 3 Hold. Therefore 40% are positive. Chemours had 8 analyst reports since July 17, 2018 according to SRatingsIntel. As per Thursday, October 11, the company rating was maintained by Citigroup. Citigroup downgraded it to “Neutral” rating and $38 target in Friday, November 2 report. Morgan Stanley maintained the stock with “Equal-Weight” rating in Tuesday, July 17 report. The firm earned “Outperform” rating on Monday, August 6 by BMO Capital Markets. The firm has “Outperform” rating given on Monday, November 5 by BMO Capital Markets. The rating was maintained by Morgan Stanley on Tuesday, September 25 with “Equal-Weight”. Below is a list of The Chemours Company (NYSE:CC) latest ratings and price target changes.

05/11/2018 Broker: BMO Capital Markets Old Rating: Outperform New Rating: Outperform Old Target: $68 New Target: $58 Maintain
02/11/2018 Broker: Citigroup Old Rating: Buy New Rating: Neutral Old Target: $44 New Target: $38 Downgrade
11/10/2018 Broker: Citigroup Old Rating: Buy New Rating: Buy Old Target: $61 New Target: $44 Maintain
25/09/2018 Broker: Morgan Stanley Old Rating: Equal-Weight New Rating: Equal-Weight Old Target: $48 New Target: $47 Maintain
06/08/2018 Broker: BMO Capital Markets Old Rating: Outperform New Rating: Outperform Old Target: $70 New Target: $68 Maintain
31/07/2018 Broker: SunTrust Rating: Hold New Target: $51 Initiates Coverage On
18/07/2018 Broker: RBC Capital Markets Rating: Outperform New Target: $60 Initiates Coverage On
17/07/2018 Broker: Morgan Stanley Old Rating: Equal-Weight New Rating: Equal-Weight Old Target: $57.5 New Target: $48 Maintain

The stock decreased 1.83% or $0.62 during the last trading session, reaching $33.22. About 1.06 million shares traded. The Chemours Company (NYSE:CC) has declined 46.99% since January 14, 2018 and is downtrending. It has underperformed by 46.99% the S&P500.

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company has market cap of $5.68 billion. It operates through three divisions: Titanium Technologies, Fluoroproducts, and Chemical Solutions. It has a 5.73 P/E ratio. The Titanium Technologies segment makes and sells titanium dioxide under the Ti-Pure brand name to deliver whiteness, brightness, opacity, and protection in various applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, PVC window profiles, laminate papers, and coated papers and paperboards used for packaging.

More recent The Chemours Company (NYSE:CC) news were published by: Seekingalpha.com which released: “Aphria completes acquisition of CC Pharma; shares up 2% premarket – Seeking Alpha” on January 09, 2019. Also Prnewswire.com published the news titled: “Carrier Selects R-454B–Sold by Chemours as Opteonâ„¢ XL41–to Replace R-410A in North America – PRNewswire” on December 19, 2018. Seekingalpha.com‘s news article titled: “Chemours: Benefiting From A Fresh Coat Of Paint – Seeking Alpha” with publication date: December 19, 2018 was also an interesting one.

The Chemours Company (NYSE:CC) Ratings Chart

(adsbygoogle = window.adsbygoogle || []).push({});

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.